通过PD-1抗体诱导的胆囊炎成功替代复发性鼻癌:一个病例报告
Zheqing Liu1, Xiaojing Du1, Meiling Deng1
1Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, 651 Dongfeng Road East, Guangzhou, 510060, P.R. China.
在PD-1抑制剂治疗后,免疫相关的胆囊炎很少见. 一名患者在治疗胆囊炎后成功接受了津比利利马布免疫疗法,并保持了完全缓解.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 与免疫相关的不良事件 (irAEs) 与免疫检查点抑制剂 (ICI) 常见.
- 免疫相关胆囊炎 (肝脏的irAEs) 和随后的免疫疗法重新挑战很少被记录.
- 鼻癌 (NPC) 的管理通常涉及ICI.
更多相关视频
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
相关概念视频
Tumor Immunotherapy
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Targeted Cancer Therapies
There are several types of targeted therapies against...
